Phase 4 Ovarian Cancer Trial, Recruiting NCT05606692 Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital Condition: Ovarian Cancer
Back to Ovarian Cancer

Phase 4 Ovarian Cancer Trial, Recruiting

NCT05606692
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 20 and 80 years old
  • You are in generally good to moderate overall health (confirm with trial site)
  • You are scheduled for a planned brain surgery (craniotomy) for a primary ovarian tumor under general anesthesia

Who may not be able to join:

  • You have a serious mental health condition
  • You have poor liver function
  • You are pregnant or currently breastfeeding
  • You are very severely overweight (morbidly obese)
  • You have had an allergic reaction to any of the medications used in this study
  • Your surgery is not specifically for primary ovarian cancer
  • You are having a type of surgery to examine ovarian cancer tissue samples (confirm with trial site)
  • Your medical records are incomplete
  • You are having additional surgeries at the same time, or your surgery is an emergency
  • You are receiving treatment for another type of cancer alongside your ovarian cancer
  • You are receiving palliative (comfort-focused) care after ovarian cancer surgery
  • The specific anesthetic drugs propofol or sevoflurane cannot be used during your surgery
  • Multiple additional anesthetic medications (such as ketamine or dexmedetomidine) are needed during your surgery
  • Your tumor has been confirmed as non-cancerous (benign) before or after surgery
  • Your ovarian tumor has spread from another part of the body to the ovary (it is not originally from the ovary)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Zhi-Fu Wu, Kaohsiung Medical University

Phone: 07-3121101

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Registry
ClinicalTrials.gov
Start date
23 November 2022
Est. completion
30 September 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

progression-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov